Trial Profile
A phase IIb "at-home" clinical trial of inhaled apomorphine in patients with Parkinson's disease.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2011
Price :
$35
*
At a glance
- Drugs Apomorphine (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Sponsors Vectura
- 13 Jun 2008 New trial record.